Growth hormone replacement therapy reduces risk of cancer in adult with growth hormone deficiency: A meta-analysis

Abstract

The risk of growth hormone on cancer in adult with growth hormone deficiency remains unclear. We carried out a meta-analysis to evaluate the risk of cancer in adult with and without growth hormone replacement therapy. We searched PubMed, Web of Science, China National Knowledge Infrastructure, and WanFang databases up to 31 July 2016 for eligible studies. Pooled risk ratio (RR) with 95% confidence interval (CI) was calculated using fixed-or random-effects models if appropriate. The Newcastle-Ottawa Scale was used to assess the study quality. Two retrospective and seven prospective studies with a total of 11191 participants were included in the final analysis. The results from fixed-effects model showed this therapy was associated with the deceased risk of cancer in adult with growth hormone deficiency (RR=0.69, 95%CI: 0.59-0.82), with low heterogeneity within studies (I2=39.0%, P=0.108). We performed sensitivity analyses by sequentially omitting one study each time, and the pooled RRs did not materially change, indicating that our results were statistically stable. Begger's and Egger's tests suggested that there was no publication bias (Z=-0.63, P=0.520; t=0.16, P=0.874). Our study suggests that growth hormone replacement therapy could reduce risk of cancer in adult with growth hormone deficiency.

Risk factors for post-thyroidectomy haemorrhage: a meta-analysis

“…The NOS was used to assess the risk of bias through three major components: (i) group selection, (ii) comparability and (iii) assessment of outcome or exposure. The total NOS scores of studies ranged from 0 to 9 (34), and studies were considered as low bias risk and high quality if they scored equal or more than 5 (35,36).…”

In Vitro and In Vivo Characterization of Novel Stable Peptidic Ghrelin Analogs: Beneficial Effects in the Settings of Lipopolysaccharide-Induced Anorexia in Mice

“…This lack of GH release could actually be an advantage for the potential use of the analogs in the treatment of anorexia/cachexia syndromes, because there is still a possibility of association between GH and tumor growth in adults. There is strong evidence from animal and cell experiments suggesting the involvement of GH in the development of tumors; however, such an association in human studies remains unclear (Li et al, 2016).…”

Clinical utility of decarboxylation prothrombin combined with α-fetoprotein for diagnosing primary hepatocellular carcinoma

“…We used the Stata 14 version (StataCorp LP, College Station, TX, U.S.A.) to conduct all the analyses. Spearman correlation coefficient was used to evaluate the threshold effect [ 12 ]. The heterogeneity was assessed via Chi-square and I 2 statistic.…”